Literature DB >> 15744523

A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype.

Jérôme Clain1, Jacqueline Lehmann-Che, Emmanuelle Girodon, Joanna Lipecka, Aleksander Edelman, Michel Goossens, Pascale Fanen.   

Abstract

In order to further elucidate the contribution of complex alleles to the wide phenotypic variability of cystic fibrosis (CF), we investigated the structure-function relationships of a severe CF-associated complex allele [p.S912L;p.G1244V]. To evaluate the contribution of each mutation to the phenotype, cystic fibrosis transmembrane conductance regulator (CFTR) mutants were expressed in HeLa cells and analysed for protein processing and Cl- channel activity. Both p.G1244V and [p.S912L;p.G1244V] mutants had normal protein processing but markedly decreased Cl- channel activity compared with wild-type. Notably, the double mutant displayed a dramatic decrease in Cl- channel activity compared with p.G1244V (P<0.001). p.S912L had normal protein processing and no detectable impact on CFTR function. In other respects, the p.S912L variation was identified in compound heterozygosity with p.R709X in a healthy fertile man. Together, these data strongly support the view that p.S912L in isolation should be considered as a neutral variant but one that might significantly impair CFTR function when inherited in cis with another CFTR mutation. Our data also further document the contribution of complex alleles to the wide phenotypic variability of CF. The results of functional studies of such complex alleles in other genetic diseases are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744523     DOI: 10.1007/s00439-004-1246-z

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression.

Authors:  M C Romey; N Pallares-Ruiz; A Mange; C Mettling; R Peytavi; J Demaille; M Claustres
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.

Authors:  J L Teem; H A Berger; L S Ostedgaard; D P Rich; L C Tsui; M J Welsh
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

3.  Severe cystic fibrosis associated with a deltaF508/R347H + D979A compound heterozygous genotype.

Authors:  S Hojo; J Fujita; H Miyawaki; Y Obayashi; J Takahara; D W Bartholomew
Journal:  Clin Genet       Date:  1998-01       Impact factor: 4.438

4.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

5.  A combined analysis of the cystic fibrosis transmembrane conductance regulator: implications for structure and disease models.

Authors:  J M Chen; C Cutler; C Jacques; G Boeuf; E Denamur; G Lecointre; B Mercier; G Cramb; C Férec
Journal:  Mol Biol Evol       Date:  2001-09       Impact factor: 16.240

6.  Two mild cystic fibrosis-associated mutations result in severe cystic fibrosis when combined in cis and reveal a residue important for cystic fibrosis transmembrane conductance regulator processing and function.

Authors:  J Clain; J Fritsch; J Lehmann-Che; M Bali; N Arous; M Goossens; A Edelman; P Fanen
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

7.  Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.

Authors:  M E Grace; P Ashton-Prolla; G M Pastores; A Soni; R J Desnick
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

8.  Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains.

Authors:  M P Anderson; M J Welsh
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

9.  Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes.

Authors:  N Monplaisir; G Merault; C Poyart; M D Rhoda; C Craescu; M Vidaud; F Galacteros; Y Blouquit; J Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Extensive analysis of 40 infertile patients with congenital absence of the vas deferens: in 50% of cases only one CFTR allele could be detected.

Authors:  T Casals; L Bassas; J Ruiz-Romero; M Chillón; J Giménez; M D Ramos; G Tapia; H Narváez; V Nunes; X Estivill
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

View more
  7 in total

Review 1.  Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids.

Authors:  Kevin G Chen; Pingyu Zhong; Wei Zheng; Jeffrey M Beekman
Journal:  Drug Discov Today       Date:  2019-06-04       Impact factor: 7.851

2.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma.

Authors:  Robert R McWilliams; Gloria M Petersen; Kari G Rabe; Leonard M Holtegaard; Pamela J Lynch; Michele D Bishop; W Edward Highsmith
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

3.  p.Ser1235Arg should no longer be considered as a cystic fibrosis mutation: results from a large collaborative study.

Authors:  Céline René; Damien Paulet; Emmanuelle Girodon; Catherine Costa; Guy Lalau; Julie Leclerc; Faïza Cabet-Bey; Thierry Bienvenu; Martine Blayau; Albert Iron; Hervé Mittre; Delphine Feldmann; Caroline Guittard; Mireille Claustres; Marie des Georges
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

4.  Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas.

Authors:  Alain Boom; Pascale Lybaert; Jean-François Pollet; Paul Jacobs; Hassan Jijakli; Philippe E Golstein; Abdullah Sener; Willy J Malaisse; Renaud Beauwens
Journal:  Endocrine       Date:  2007-11-27       Impact factor: 3.633

5.  Non-syndromic hearing loss caused by the dominant cis mutation R75Q with the recessive mutation V37I of the GJB2 (Connexin 26) gene.

Authors:  Juwon Kim; Jinsei Jung; Min Goo Lee; Jae Young Choi; Kyung-A Lee
Journal:  Exp Mol Med       Date:  2015-06-19       Impact factor: 8.718

6.  N1303K (c.3909C>G) mutation and splicing: implication of its c.[744-33GATT(6); 869+11C>T] complex allele in CFTR exon 7 aberrant splicing.

Authors:  Raëd Farhat; Géraldine Puissesseau; Ayman El-Seedy; Marie-Claude Pasquet; Catherine Adolphe; Sandra Corbani; André Megarbané; Alain Kitzis; Véronique Ladeveze
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

7.  A pseudo-dominant form of Gitelman's syndrome.

Authors:  Renaud de La Faille; Marion Vallet; Annabelle Venisse; Valérie Nau; Carole Collet-Gaudillat; Pascal Houillier; Xavier Jeunemaitre; Rosa Vargas-Poussou
Journal:  NDT Plus       Date:  2011-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.